Evidence map›Paper›PMID 40792473›Full record

ReviewAnnals of medicine2025

Research progress of potassium-competitive acid blockers in the treatment of

Zhaoli Ma, Shiling Wang, Furui Wang, Qian Ren

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Annals of medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Review
  6. Potassium-competitive acid blockers forFrontiers in cellular and infection microbiology · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Zhaoli MaThe First School of Clinical Medicine, Lanzhou University, Lanzhou, Gansu Province, China.ORCID 0009-0000-9517-0800
Shiling WangGansu Health Vocational College, Lanzhou, Gansu Province, China.
Furui WangThe First School of Clinical Medicine, Lanzhou University, Lanzhou, Gansu Province, China.
Qian RenThe First School of Clinical Medicine, Lanzhou University, Lanzhou, Gansu Province, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Helicobacter InfectionsHelicobacter pyloriProton Pump InhibitorsAnti-Bacterial AgentsCytochrome P-450 CYP2C19Drug Therapy, CombinationH(+)-K(+)-Exchanging ATPaseHumansPotassiumTreatment OutcomeAnti-Bacterial AgentsCYP2C19 protein, humanCytochrome P-450 CYP2C19H(+)-K(+)-Exchanging ATPasePotassiumProton Pump InhibitorsEradication therapygut microbiotaHelicobacter pyloripotassium-competitive acid blocker

Identifiers

PMID40792473
PMCPMC12344716

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.